GENERALIZED MYASTHENIA GRAVIS
Clinical trials for GENERALIZED MYASTHENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new GENERALIZED MYASTHENIA GRAVIS trials appear
Sign up with your email to follow new studies for GENERALIZED MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study tests best way to dose Muscle-Weakening disease drug
Disease control CompletedThis study tested two different dosing schedules for an intravenous drug called efgartigimod in adults with generalized myasthenia gravis (gMG), a condition that causes muscle weakness. Researchers wanted to see if giving the drug continuously worked better than giving it in cycl…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Apr 04, 2026 05:05 UTC
-
New drug shows promise for debilitating Muscle-Weakening disease
Disease control CompletedThis study tested whether a drug called rozanolixizumab could safely reduce symptoms and improve daily life for adults with generalized myasthenia gravis, a disease that causes severe muscle weakness. In this Phase 3 trial, 200 participants were randomly assigned to receive eithe…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Patients learn to give their own myasthenia gravis shots at home
Disease control CompletedThis study tested whether people with generalized myasthenia gravis (gMG) could safely give themselves their medication at home after training. Researchers taught 62 participants how to use two different injection methods and monitored their success and safety. The goal was to ma…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
At-Home injection offers new hope for Muscle-Weakening disease
Disease control CompletedThis study tested if people with generalized myasthenia gravis (gMG), a chronic autoimmune disease that causes muscle weakness, could safely switch from receiving their medication through regular intravenous (IV) infusions at a clinic to giving themselves a daily injection (ziluc…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Patients successfully Self-Inject Muscle-Weakness medication at home
Disease control CompletedThis study tested whether people with generalized myasthenia gravis (a condition causing muscle weakness) could safely and effectively give themselves their medication using a new auto-injector device at home. Thirty-one adults who were already taking the medication zilucoplan pa…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New injection shows promise for Long-Term muscle disease control
Disease control CompletedThis study tested the long-term safety and effectiveness of a medication called efgartigimod, given as an injection under the skin, for people with generalized myasthenia gravis (gMG). It involved 184 adults who had previously benefited from the treatment in earlier studies. The …
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC